Patents by Inventor André Beaulieu

André Beaulieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9837880
    Abstract: A magnetic voltage/current limiting system is mounted in conjunction with a main coil, in a coil assembly of a wind turbine generator, for limiting the outputted voltage (or current) to a predetermined upper value. The limiting system generally has at least one limiting coil and a control circuit connected to the main coil. The limiting system is configured to be activated when the voltage (or current) outputted by the main coil increases beyond the predetermined upper value. Once activated, the limiting system diverts a portion of the outputted current to the limiting coil such as to generate a magnetic field in the limiting coil. This additional magnetic field generally limits the amount magnetic field generated by passing magnets to flow through the main coil, thereby limiting the outputted voltage.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: December 5, 2017
    Inventor: André Beaulieu
  • Publication number: 20160164379
    Abstract: A magnetic voltage/current limiting system is mounted in conjunction with a main coil, in a coil assembly of a wind turbine generator, for limiting the outputted voltage (or current) to a predetermined upper value. The limiting system generally comprises at least one limiting coil and a control circuit connected to the main coil. The limiting system is configured to be activated when the voltage (or current) outputted by the main coil increases beyond the predetermined upper value. Once activated, the limiting system diverts a portion of the outputted current to the limiting coil such as to generate a magnetic field in the limiting coil. This additional magnetic field generally limits the amount magnetic field generated by passing magnets to flow through the main coil, thereby limiting the outputted voltage.
    Type: Application
    Filed: November 19, 2014
    Publication date: June 9, 2016
    Inventor: André BEAULIEU
  • Publication number: 20150130331
    Abstract: A magnetic voltage/current limiting system is mounted in conjunction with a main coil, in a coil assembly of a wind turbine generator, for limiting the outputted voltage (or current) to a predetermined upper value. The limiting system generally comprises at least one limiting coil and a control circuit connected to the main coil. The limiting system is configured to be activated when the voltage (or current) outputted by the main coil increases beyond the predetermined upper value. Once activated, the limiting system diverts a portion of the outputted current to the limiting coil such as to generate a magnetic field in the limiting coil. This additional magnetic field generally limits the amount magnetic field generated by passing magnets to flow through the main coil, thereby limiting the outputted voltage.
    Type: Application
    Filed: November 19, 2014
    Publication date: May 14, 2015
    Inventor: André BEAULIEU
  • Patent number: 6528483
    Abstract: Aqueous, non-buffered solutions containing high concentrations of fibronectin and other wound healing promoters are produced, which can then be used to make topical gel and cream formulations with high concentrations of these wound healing promoters. The formulations are used for the healing of cutaneous wounds. The formulations provide slow release and increased contact time of fibronectin and of other wound healing promoters to the wound site leading to effective absorption of the promoters.
    Type: Grant
    Filed: August 21, 1999
    Date of Patent: March 4, 2003
    Inventors: André Beaulieu, Robert Paquin
  • Patent number: 6251859
    Abstract: A deepithelialized skin cell diffusion system which can be used to select topical gel and cream formulations containing human other wound healing promoters such as plasma fibronectin. The formulations provide slow release and increased contact time of fibronectin or other wound healing promoters to the wound site leading to its effective absorption.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: June 26, 2001
    Inventor: André Beaulieu